Adult Stem Cells Market to Reach USD 9.45 Billion by 2028

Vantage Market Research

Nov 11, 2021

According to analysts at Vantage Market Research, the Adult Stem Cells Market is expected to reach USD 9.45 Billion by 2028, growing at a CAGR of 7.5% from 2021 to 2028.

Expanding interest for biologics, innovative progression in immature microorganism therapeutics, and a developing spotlight on the improvement of customized drugs. The expanding center around the treatment of neurological problems adds to the market extension. As indicated by the World Health Organization (WHO), the all-out worldwide burden of diseases is cerebrovascular disorders and neurological problems. Subsequently, organizations are directing essential exploration and preclinical tests for examining the regenerative limit of stem cells in the treatment of neurological conditions.

Key Findings:

  • The epithelial stem cells segment is projected to expand at the fastest CAGR exceeding 7% over the forecast period owing to the rising demand for biologics, advancement in technology in stem cell therapeutics, and rising focus on the advancement of personalized medicines.
  • The neurodegenerative diseases segment held a market share of around 5% in 2020. This share is due to the rising focus on the medical care of neurological disorders is also fueling the market expansion.
  • North America is expected to expand at a CAGR of over 8% from 2021 to 2028. This surge is attributed to the rising demand for the adult stem cells market in developed economies such as U.S. and Canada.

 There is an expanding number of stem cell banks, which work together with clinics and grow awareness about the capacity of cord blood units in families. The support is expanding with the rising number of clinical networks and government initiatives active in advancing the utilization of undeveloped cells for the treatment of more than a hundred infections.

North America region is poised to record the highest CAGR, owing to the increasing demand in countries, such as the U.S., Canada, and Mexico, coupled with the growth of the region's overall adult stem cells market. As of now, there is an increase in the number of clinical tests for examining future treatment prospects of stem cells.

 

Some of the key players in the Adult Stem Cells Market include Intellicell Biosciences Inc., Globalstem, Neurodegeneration, Capricor Inc., Caladrius Biosciences Inc., Mesoblast Ltd., Celyad, Juventas Therapeutics Inc., Cytori Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Brainstorm Cell Therapeutics Inc., Cellerant Therapeutics Inc., Hybrid Organ Gmbh, Cellerix Sa., among others.  The market is comprised of a high degree of competition due to the presence of numerous key players. Manufacturers are focusing on opting for various inorganic growth strategies such as acquisitions, mergers, and geographical expansion to leverage their market share and gain a competitive advantage.